Leading American Dermatologist Dr. Mitchell Kline to Join Innocan Pharma’s Scientific Advisory Committee

Posted by Newsfile March 23, 2021

Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – March 23, 2021) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink: INNPF) (the “Company” or “Innocan”) is proud to announce the addition of Dr. Mitchell Kline to its Scientific Advisory Committee. Dr. Kline will serve as an active member of Innocan’s R&D team, using his extensive experience in researching and treating different skin conditions, to further develop Innocan’s derma cosmetic line.

 

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/78223

Powered by WPeMatico

Tags:
Newsfile
View More Posts
Newsfile is a customer-focused newswire team that delivers press releases and corporate announcements to the global financial community. Approved by all stock exchanges, Newsfile offers broad access to media, analysts, investors and market participants. With agile services, proactive customer care and affordable pricing; Newsfile makes it easy for companies to tell their story to the audiences they need to reach.